Reaction

Livedo Reticularis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,059 reports · 50 co-occurring drugs

As of the last recalculation, Livedo Reticularis appears in 2,059 FAERS reports alongside 50 co-occurring drug terms. The strongest observed disproportionality signal is IRON SUCROSE (PRR 34.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Iron Sucrose	32	34.5	34.6
Amantadine	50	33.5	33.6
Desloratadine	25	23.8	23.9
Piperacillin And Tazobactam	20	16.0	16.0
Norepinephrine Bitartrate	21	14.9	14.9
Sirolimus	19	14.4	14.4
Panitumumab	21	13.7	13.7
Ampicillin	11	13.5	13.5
Ampicillin Sodium	11	13.5	13.5
Norepinephrine	14	13.3	13.3
Piperacillin Sodium And Tazobactam Sodium	24	12.5	12.5
Iohexol	9	11.0	11.0
Ketoprofen	14	10.9	10.9
Nebivolol	14	8.9	8.9
Agalsidase Beta	8	8.8	8.8
Sotalol Hydrochloride	14	8.6	8.6
Oxazepam	18	8.5	8.5
Rifampin	12	8.4	8.4
Piperacillin Sodium,Tazobactam Sodium	21	8.1	8.1
Rocuronium Bromide	9	7.8	7.8
Daptomycin	7	7.7	7.7
Fexofenadine	12	7.4	7.4
Sevoflurane	6	7.3	7.3
Minocycline	8	7.0	7.0
Bosutinib	6	6.8	6.8
Acetaminophen And Codeine	8	6.7	6.7
Palivizumab	10	6.6	6.6
Vancomycin	37	6.6	6.6
Filgrastim	24	6.5	6.5
Vancomycin Hydrochloride	41	6.4	6.4
Rasagiline Mesylate	7	6.4	6.4
Fondaparinux Sodium	5	6.3	6.3
Polatuzumab Vedotin	6	6.2	6.2
Bleomycin Sulfate	6	5.9	5.9
Cefepime Hydrochloride	9	5.7	5.7
Alteplase	8	5.4	5.4
Pyrazinamide	5	5.4	5.4
Remdesivir	7	5.3	5.3
Interferon Beta-1B	10	5.3	5.3
Busulfan	8	5.2	5.2
Amphetamine	4	4.9	4.9
Gemcitabine Hydrochloride	24	4.6	4.6
Carbidopa And Levodopa	20	4.3	4.3
Prasugrel Hydrochloride	4	4.0	4.0
Gemcitabine	15	3.9	3.9
Methylphenidate	11	3.9	3.9
Medroxyprogesterone Acetate	16	3.3	3.3
Rimegepant Sulfate	4	3.2	3.2
Teriflunomide	13	2.9	2.9
Paricalcitol	4	2.9	2.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.